Valganciclovir for cytomegalovirus viraemia in advanced HIV disease: a phase 2b randomized placebo-controlled trial of valganciclovir for cytomegalovirus viraemia in adults and adolescents with advanced HIV disease. - Ellis J; Nsangi LJ; Rassool M; Musaazi J; Lawrence DS; Skipper C; Boulware DR; Meya DB; Wasserman S; Jarvis JN; Boyles T (Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2025)